The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (P) or P + chemotherapy (C) versus EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): analysis of KEYNOTE-048 by disease state.
 
Danny Rischin
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Regeneron
Travel, Accommodations, Expenses - Merck
 
Kevin Joseph Harrington
Honoraria - Amgen (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Mersana (Inst); Oncolys BioPharma (Inst); Pfizer (Inst); Replimune (Inst)
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Replimune (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Sharp & Dohme (Inst); Replimune (Inst)
 
Richard Greil
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Denis Soulieres
Honoraria - Adlai Nortye; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Makoto Tahara
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Serono; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; MSD; Ono Pharmaceutical; Pfizer; Rakuten Medical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Loxo (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Rakuten Medical (Inst)
 
Gilberto Castro
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche; Teva; Yuhan
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Amanda Psyrri
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Genesis Pharmaceuticals; Merck Serono; MSD Oncology; Pfizer; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Pfizer; Rakuten Medical
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; AstraZeneca
 
Neus Baste
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Nanobiotix
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix
 
Prakash C. Neupane
Consulting or Advisory Role - Pfizer/EMD Serono
Research Funding - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Åse Bratland
No Relationships to Disclose
 
Thorsten Fuereder
Honoraria - Accord Healthcare; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Roche; Sanofi
Consulting or Advisory Role - Amgen; Merck; MSD; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche; Sanofi/Regeneron
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Ricard Mesia
Consulting or Advisory Role - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck KGaA; MSD; Nanobiotix; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA; Roche
 
Nuttapong Ngamphaiboon
Honoraria - Amgen; AstraZeneca; Eisai; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; MSD; Novartis; Roche; Taiho Pharmaceutical
Speakers' Bureau - Amgen; AstraZeneca; Eisai; MSD; Novartis; Roche
Research Funding - AstraZeneca; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; Eisai; Merck; MSD; Novartis; Roche; Taiho Pharmaceutical
 
Tamara Rordorf
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
 
Wan Zamaniah Wan Ishak
Honoraria - Amgen; Eisai; Eisai; Ipsen; Lilly; Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Consulting or Advisory Role - Celgene; Celgene; Eisai; Lilly; Merck Sharp & Dohme
Research Funding - AstraZeneca; Merck Sharp & Dohme; Roche/Genentech
Travel, Accommodations, Expenses - Celgene; Eisai; Lilly; Pfizer
 
Jianxin Lin
Employment - Merck
 
Burak Gumuscu
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Ramona F. Swaby
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Barbara Burtness
Honoraria - AstraZeneca
Consulting or Advisory Role - Aduro Biotech; Alligator Bioscience; ALX Oncology; AstraZeneca; Bristol-Myers Squibb; Celgene; CUE Biopharma; Debiopharm Group; GlaxoSmithKline; Macrogenics; Maverick Therapeutics; Merck; Nanobiotix; Rakuten Medical
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Formation Biologics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Debiopharm Group; Merck